We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Metronomic Temozolamide in Patients With Recurrent Glioblastoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01308632
Recruitment Status : Unknown
Verified March 2011 by Grupo Español de Investigación en Neurooncología.
Recruitment status was:  Active, not recruiting
First Posted : March 4, 2011
Last Update Posted : March 4, 2011
Information provided by:
Grupo Español de Investigación en Neurooncología

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : June 2012
  Estimated Study Completion Date : June 2012